arrow
D

Dong Xiao

merck & co., inc.
H指数:17
被引数:721

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors

发现强效且选择性苯并噻吩二氟甲基磷酸酯(DFMP)PTPN2/N1-双抑制剂

2026-04-290
PRE
Discovery of Potent 1; 3-Cyclobutane-Containing Dual A2A/A2B Receptor Antagonists with Low Projected Human Dose for the Treatment of Cancer

具有低剂量潜力的含1,3-环丁烷基的双A2A/A2B受体拮抗剂的发现及其在癌症治疗中的应用

2026-04-140
PRE
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease (vol. 69, pg. 8548, 2026)

发现强效、选择性、中枢神经系统穿透性大环LRRK2抑制剂用于帕金森病的治疗(vol. 69, pg. 8548, 2026)

2026-04-010
PRE
Discovery of Potent; Selective; CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson’s Disease

发现强效、选择性、能穿透中枢神经系统的环状LRRK2抑制剂,用于帕金森病的治疗

2026-03-290
PRE
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
2023-10-205
PRE
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMs
2018-06-149
OAAI
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
2011-11-2932
OAAI
Discovery of a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
2010-12-0819
OA